Acitretin, sold under the brand names Neotigason and Soriatane, is a second-generation retinoid. It is taken orally, and is typically used for psoriasis. It was patented in Germany in 1974 and approved for medical use in the United States in 1996.
Acitretin molecular structure diagram from the DrugsPRO substance library.
Also known as: Etretinate
Classification
Chemical: Medicine
Effects
No data available for this section yet.
Routes of Administration
No route information available yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
This static page is intended as a readable non-JS and prerender-friendly library export.
Get the full DrugsPRO experience
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
Acitretin - Treoir substaint DrugsPRO
Acitretin: Acitretin, sold under the brand names Neotigason and Soriatane, is a second-generation retinoid. It is taken orally, and is typically used for psoriasis. It was patented in Germany in 1974 and approved for medical use in the United States in 1996.